利索-全球专利检索

  1. 登录
  2. 注册
发明授权
US09492476B2 Potassium-binding agents for treating hypertension and hyperkalemia 有权
用于治疗高血压和高钾血症的钾结合剂

Potassium-binding agents for treating hypertension and hyperkalemia
摘要：
The present invention generally relates to methods of treating hypertension (HTN) in patients in need thereof wherein the patient optionally further suffers from chronic kidney disease (CKD) or Type II diabetes mellitus (T2DM). The invention also relates to methods of treating hyperkalemia in a patient in need thereof, wherein the patient suffers from CKD, T2DM or HTN and are optionally being treated with an effective amount of a renin-angiotensin-aldosterone system (RAAS) agent. The invention also relates to methods of treating kidney disease in a patient in need thereof, wherein the patient is optionally being treated with an effective amount of a renin-angiotensin-aldosterone system (RAAS) agent. The methods can comprise administering an effective amount of a potassium-binding agent to the patient to lower the patient's blood pressure and/or increase or stabilize the patient's kidney function.
摘要（中）：

本发明一般涉及在有需要的患者中治疗高血压（HTN）的方法，其中患者任选地进一步患有慢性肾脏疾病（CKD）或II型糖尿病（T2DM）。 本发明还涉及在有需要的患者中治疗高钾血症的方法，其中患者患有CKD，T2DM或HTN，并且任选地用有效量的肾素 - 血管紧张素 - 醛固酮系统（RAAS）药物治疗。 本发明还涉及在有需要的患者中治疗肾病的方​​法，其中所述患者任选地用有效量的肾素 - 血管紧张素 - 醛固酮系统（RAAS）药物治疗。 所述方法可以包括向患者施用有效量的结合钾的剂量以降低患者的血压和/或增加或稳定患者的肾功能。

公开/授权文献
信息查询
Espacenet
0/0